Deep-Learning-Assisted Analysis of Early Biomarker Changes in Treatment-Naïve Patients with Neovascular AMD Under Intravitreal Faricimab

Abstract Introduction Artificial intelligence (AI)-driven biomarker segmentation offers an objective approach to assessing neovascular age-related macular degeneration (nAMD). In addition, faricimab, a bispecific VEGF and Ang-2 inhibitor, presents new potential in disease management. This study appl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Michael Hafner, Ben Asani, Franziska Eckardt, Jakob Siedlecki, Benedikt Schworm, Siegfried G. Priglinger, Johannes Schiefelbein
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2025-03-01
Colecção:	Ophthalmology and Therapy
Assuntos:	Artificial intelligence Biomarker Faricimab Neovascular age-related macular degeneration (nAMD) Real-world data
Acesso em linha:	https://doi.org/10.1007/s40123-025-01125-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!